CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 169 enrolled
Drug / intervention
Duac Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00807014
NCT00807014Phase 4Completed
CompareCT.gov

Single-blind, Multicenter, Parallel, Comparative, Randomized, Phase 4 Clinical Trial for the Evaluation of the Quality of Life, Efficacy and Tolerance of Duac® Gel Against Differin® Gel in the Topical Treatment of Mild to Moderate Acne Vulgaris.

Stiefel, a GSK Company·interventional·Posted Dec 11, 2008·Updated Mar 20, 2012

In Brief

A Phase 4 clinical trial evaluating Duac Gel and Differin gel for Acne Vulgaris. Completed, enrolled 169 participants across 8 sites.

Detailed Summary

The objectives of this clinical trial are to compare the quality of life of the subjects, the efficacy and the tolerance of Duac® Gel (gel formulation with a combination of clindamycin phosphate \[equivalent to 1% clindamycin\] and 5% benzoyl peroxide), applied once daily, against Differin® Gel (gel with 0.1% adapalene), used once daily, in the treatment of mild to moderate acne vulgaris.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesSpain
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 11, 2008
Enrollment StartNov 1, 2006
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.6 years ago

Interventions

Duac Geldrug

Duac® Gel will be applied to the face once daily at night, for 12 weeks.

Differin geldrug

Differin Gel will be applied to the face once daily at night, for 12 weeks.